Levy Raphi 4
4 · Alpha Tau Medical Ltd. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Alpha Tau Medical (DRTS) CFO Raphi Levy Sells Shares
What Happened Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd. (DRTS), reported two sales of company stock on 2026-06-25. Levy disposed of 4,222 shares at $11.00 each (reported value $46,443) and 15,778 shares at $11.00 each (reported value $173,561), for a combined total of 20,000 shares and $220,004. These were reported as sales (S) — dispositions rather than purchases or option exercises.
Key Details
- Transaction dates and prices: 2026-06-25 — 4,222 shares @ $11.00 and 15,778 shares @ $11.00.
- Reported proceeds: $46,443 and $173,561, respectively; combined ~$220,004.
- Transaction type: Sales (S), reported as open-market or private sale on Form 4.
- Shares owned after transaction: Not disclosed in the provided excerpt of the filing — see the full Form 4 for post-transaction holdings.
- Filing timeliness: Form filed 2026-06-26 for transactions on 2026-06-25 (timely filing).
- No footnotes in the provided data indicating a 10b5-1 plan, tax withholding, or cashless exercise.
Context Insider sales are often for personal liquidity and do not necessarily signal negative views about the company. Purchases tend to be viewed as a clearer bullish indicator. For full context (total insider holdings, any plan-based sales, or more detail), retail investors should review the complete Form 4 filing (Accession 0001213900-26-072349) on the SEC EDGAR site.
Insider Transaction Report
- Sale
Ordinary Shares
2026-06-25$11.00/sh−4,222$46,443→ 125,958 total - Sale
Ordinary Shares
2026-06-25$11.00/sh−15,778$173,561→ 110,180 total